Roth Capital analyst Bill Kirk lowered the firm’s price target on Flora Growth (FLGC) to $30 from $58.50 and keeps a Buy rating on the shares. The company continues to re-focus its business toward more profitable U.S./European branded opportunities, but took a step back this quarter as gross margin pressure impacted bottom line results, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGC: